Lung Cancer Europe/LinkedIn
Aug 10, 2025, 04:25
What is Radioligand Therapy for Lung Cancer? – Lung Cancer Europe
Lung Cancer Europe shared a post on LinkedIn:
“Radioligand therapy is a growing area of cancer research – including in lung cancer.
It uses a radioactive drug to find and destroy cancer cells from the inside. The “ligand” targets the tumour. The radioactive part delivers a controlled dose of radiation.
It’s already used in prostate and neuroendocrine cancers. Now it’s being studied in small cell lung cancer, especially where a protein called DLL3 is present.
It’s not widely available yet, but research is moving fast. This could offer a new targeted option where few others exist.”
More posts featuring Lung Cancer Europe.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 12:37
Aug 25, 2025, 12:23
Aug 25, 2025, 11:07
Aug 25, 2025, 09:45